Elite in Anal Cancer

Richard A. Adams

Cardiff University Heath Park, 
Cardiff, WLS, GB 
Elite in Anal Cancer
Cardiff University Heath Park, 
Cardiff, WLS, GB 
OverviewLocationsClinical Research

Overview

Richard Adams practices in Cardiff, United Kingdom. Mr. Adams is rated as an Elite expert by MediFind in the treatment of Anal Cancer. His top areas of expertise are Colorectal Cancer, Anal Cancer, Gastrointestinal Perforation, Colostomy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 140 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Anal Cancer.

Gender
Male

Locations

Cardiff University Heath Park, Cardiff, WLS, United Kingdom
Other Locations
Heath Park, Cardiff, WLS, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 13, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

140 Total Publications

ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine.
ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine.
Journal: Future oncology (London, England)
Published: July 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Adams's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile